You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Collapsible and Protective Portable Canine Shelter

    SBC: MANTEL TECHNOLOGIES, INC.            Topic: CBD222003

    In this SBIR program, Mantel Technologies will develop an innovative, light weight, rapidly deployable canine shelter for use in response to chemical warfare agent threats. The shelter will be capable of filtering particulates and absorbing a wide range of chemical warfare agents and will meet canine behavioral, anatomical and physiological needs including shelter temperature regulation and airflo ...

    SBIR Phase I 2023 Department of DefenseOffice for Chemical and Biological Defense
  2. Designer Protein Therapeutics as Medical Countermeasures Against Organophosphate Chemical Warfare Agents: Evaluation and Optimization of Lead Computationally Designed Non-Immunogenic Enzymes

    SBC: ARZEDA Corp.            Topic: BCET3

    The goal of this proposal is it to use computational protein design to develop a set of stable, non-immunogenic enzymes for G-agent and V-agent neurotoxin deactivation based on an engineered human PON1 scaffold suitable for mass production. Chemical warfare nerve agents (CWNAs) have existed for over a century and remain a serious threat to the safety of mankind. Therapeutic enzyme treatments offer ...

    SBIR Phase II 2022 Department of DefenseOffice for Chemical and Biological Defense
  3. Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents

    SBC: IMPEL NEUROPHARMA, INC.            Topic: CBD10109

    Technical Abstract Impel NeuroPharma has developed a novel non-invasive delivery system, the POD device that targets drug to the upper third of the nasal cavity which results in direct and rapid transport of drug to the CNS via the olfactory perineural pathways, effectively bypassing the BBB. In Phase I of this research contract Impel successfully characterized and tested both an aqueous and a ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
  4. Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents

    SBC: IMPEL NEUROPHARMA, INC.            Topic: CBD10109

    This program plans to develop a drug delivery system that provides maximum oxime drug exposure and improve cholinesterase reactivation in the brain and tissues of central nervous system (CNS) of a warfighter after exposure to organophosphate (OP) poisoning. The greatest need for improvement in cholinesterase reactivation is the ability to deliver charged cholinesterase reactivators to the CNS tha ...

    SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense
  5. Omni-Directional, Wind and Water Tolerant Inlet for the DFU

    SBC: ENERTECHNIX, INC.            Topic: CBD07116

    The current DFU inlet exhibits poor aerosol sampling efficiency at high wind speeds. This project will develop an improved inlet with very high sampling efficiency for 1 to 20 micron particles at wind speeds up to 30 mph independent of wind direction. The project is focused on the DFU, but our Aerodynamic Next Generation Inlet (ANGI) will be beneficial for any high volume aerosol sampling applicat ...

    SBIR Phase II 2008 Department of DefenseOffice for Chemical and Biological Defense
  6. Omni-Directional, Wind and Water Tolerant Inlet for the DFU

    SBC: ENERTECHNIX, INC.            Topic: CBD07116

    In the proposed project, Enertechnix will develop optimized designs for an improved inlet for the Dry Filter Unit (DFU) capable of achieving high collection efficiencies for particles between 1 and 20 microns in diameter while functioning reliably on board naval vessels. This new inlet will be insensitive to wind direction and speed and will be tolerant of harsh weather and wave conditions. By inc ...

    SBIR Phase I 2007 Department of DefenseOffice for Chemical and Biological Defense
  7. Point Detector for Biological Material Identification

    SBC: Fluid Analytics, Inc            Topic: N02118

    MicroEnergy Technologies (MicroET) in conjunction with ChemImage Inc. (Pittsburg, PA) has a goal to develop an efficient pathogen collector and detector that can be deployed as a point detector with few false alarms. During Phase I we developed a prototy

    SBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense
  8. Active Air Filtration and Purification System for Nerve Agent Mists and Vapors

    SBC: Fluid Analytics, Inc            Topic: CBD04303

    MicroEnergy Technologies, Inc. (MicroET) in conjunction with Honeywell (formerly Allied-Signal) proposes to develop a unique and revolutionary filter approach for actively removing hazardous (small particle) mists and toxic chemicals such as nerve agents from air. MicroET has significant experience in the development of microstructures for filtration and heat transfer. The combination of a micro ...

    SBIR Phase I 2004 Department of DefenseOffice for Chemical and Biological Defense
  9. Molecular Signatures of Biological Pathogens

    SBC: ILLUMIGEN BIOSCIENCES, INC.            Topic: N/A

    This Phase II continuation of ongoing research aims to extend our existing database of human molecular response to infection with biological pathogens. We will compile gene expression changes that are predictive of infection with a larger variety ofbacterial and viral pathogens. The ultimate goal is to perform analyses that may form the basis for a commercial microarray product aimed at early an ...

    SBIR Phase II 2003 Department of DefenseOffice for Chemical and Biological Defense
  10. Molecular Signatures of Biological Pathogens

    SBC: ILLUMIGEN BIOSCIENCES, INC.            Topic: N/A

    "This proposal is in response to a request for applications from the Chemical and Biological Defense program. Illumigen Biosciences Inc. proposes a series of experiments to explore the utility of using DNA microarrays as a tool to detect gene expressionchanges that are diagnostic of exposure to biological agents. The ultimate goal of a combined Phase I and II project will be to develop a database ...

    SBIR Phase I 2002 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government